Skip to main content

‘aortic valve disease’

Antibody developed for rheumatoid arthritis could improve heart attack recovery

Sep. 23, 2019—More than one million Americans per year experience myocardial infarction, commonly known as a heart attack, as well as the healing and rebuilding phase that begins shortly thereafter – a complicated process which involves remodeling and repairing the heart. This process is known as the granulation phase and is critical for healing. But due to...

Read more


Study links Celebrex, heart valve calcification after earlier research declared drug safe

Feb. 22, 2019—A well-known, four-year study found popular arthritis drug Celebrex no more dangerous for the heart than older drugs in its same classification – commonly called NSAIDs. Now, a big-data analysis of patient records at Vanderbilt University has found a link specifically between Celebrex and heart valve calcification. W. David Merryman, professor of biomedical engineering, Meghan...

Read more


Heart valve disease research earns grad student a young investigator award

Apr. 24, 2017—A biomedical engineering graduate student at Vanderbilt University has received a young investigator award for her work on heart valve disease. Doctoral student Meghan Bowler won the Allan D. Callow Young Investigator Award for best poster presentation at the 15th biennial meeting of the International Society for Applied Cardiovascular Biology. Bowler investigates the mechanism of calcific...

Read more